John F. Bierbaum
Directeur/Membre du Conseil chez Holstein USA, Inc.
Profil
John F.
Bierbaum has been a Director of Northfield Laboratories, Inc. since September 2002.
He is Chief Financial Officer of Archdiocese of Saint Paul and Minneapolis.
Mr. Bierbaum is a Director of Holstein USA, Inc. He was a Senior Officer of PepsiAmericas, Inc. Mr. Bierbaum had been a Consultant of PepsiAmericas, Inc. since May 2003.
He received a BS degree from the University of Minnesota in 1967 and is a Certified Public Accountant.
Postes actifs de John F. Bierbaum
| Sociétés | Poste | Début |
|---|---|---|
| Holstein USA, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de John F. Bierbaum
| Sociétés | Poste | Fin |
|---|---|---|
Archdiocese of Saint Paul & Minneapolis
 Archdiocese of Saint Paul & Minneapolis Other Consumer ServicesConsumer Services Archdiocese of Saint Paul & Minneapolis operates elementary and secondary schools. The company was headquartered in St. Paul, MN. | Directeur Financier/CFO | 03/12/2014 |
Northfield Laboratories, Inc.
 Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Directeur/Membre du Conseil | 10/11/2009 |
Formation de John F. Bierbaum
| University of Minnesota | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Health Technology |
| Holstein USA, Inc. | |
Archdiocese of Saint Paul & Minneapolis
Archdiocese of Saint Paul & Minneapolis Other Consumer ServicesConsumer Services Archdiocese of Saint Paul & Minneapolis operates elementary and secondary schools. The company was headquartered in St. Paul, MN. | Consumer Services |